AGMB-447 clinical trials

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

This study is testing a new inhaled medicine, AGMB-447, for idiopathic pulmonary fibrosis (IPF). Researchers want to see if it's safe and how it works in healthy volunteers and people with IPF. It's an early-stage trial comparing the medicine to a dummy treatment (placebo).